APA (7th ed.) Citation

Fiedler, W., & Kayser, S. (2015). A phase I/II study of sunitinib and intensive chemotherapy in patients over 60 years of age with acute myeloid leukaemia and activating FLT3 mutations. British journal of haematology, 169(5), . https://doi.org/10.1111/bjh.13353

Chicago Style (17th ed.) Citation

Fiedler, Walter, and Sabine Kayser. "A Phase I/II Study of Sunitinib and Intensive Chemotherapy in Patients over 60 Years of Age with Acute Myeloid Leukaemia and Activating FLT3 Mutations." British Journal of Haematology 169, no. 5 (2015). https://doi.org/10.1111/bjh.13353.

MLA (9th ed.) Citation

Fiedler, Walter, and Sabine Kayser. "A Phase I/II Study of Sunitinib and Intensive Chemotherapy in Patients over 60 Years of Age with Acute Myeloid Leukaemia and Activating FLT3 Mutations." British Journal of Haematology, vol. 169, no. 5, 2015, https://doi.org/10.1111/bjh.13353.